Sol-Gel Technologies SLGL
NASDAQ SLGL
$65.96 +1.06 (+1.63%)
As of: Oct 20, 2026 · 1:24 PM EDT

Sol-Gel Technologies (SLGL) Non-Current Debt (2025)

Updated

Sol-Gel Technologies' Non-Current Debt came in at $1.36 million for Q2 2025.

Analysis

Sol-Gel Technologies (SLGL) Non-Current Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,156.05 Bn 1,124.64 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.19 Bn 542.72 Bn 17.26 Bn 37.34 Bn
3 AbbVie 512.15 Bn 485.26 Bn 12.70 Bn 62.48 Bn
4 Merck 365.34 Bn 319.72 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.35 Bn 261.34 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn 23.68 Bn
7 Amgen 234.73 Bn 190.13 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 193.00 Bn 167.20 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 60.50 Bn
10 Sol-Gel Technologies 183.76 Mn 38.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.36 Mn
API Access

Sol-Gel Technologies Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=SLGL&period=max&api_key=YOUR_API_KEY